Barzolvolimab (CDX-0159) Palmoplantar/Genital Psoriasis Clinical Trial

Do you have Psoriasis?

OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with psoriasis will receive free biologic medication. Volunteer today and help pave the next generation of psoriasis treatments.

Duration

Study length is 60 weeks after enrollment. There are a total of 15 in-person visits required. Participants will be compensated for time and travel.

Study Specifics

For adult patients 18+ who have been diagnosed with psoriasis. Patients must be treated with Barzolvolimab (CDX-0159) therapy once enrolled.

Eligibility

To participate, you MUST have:

Psoriasis

You will NOT be eligible if:

you have received Otezla® (apremilast) in the past
your child is currently enrolled in another clinical trial